Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia.
作者信息
Kuo Dennis John, Spies Jeanie Marie, Le Floch Nathalie, Wong Victor
机构信息
Pediatric Hematology-Oncology, University of California San Diego School of Medicine, La Jolla, California, USA
Pediatric Hematology-Oncology, Rady Children's Hospital San Diego, San Diego, California, USA.
出版信息
BMJ Case Rep. 2021 Nov 30;14(11):e246596. doi: 10.1136/bcr-2021-246596.
Abstract
摘要
相似文献
1
Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia.急性髓系白血病阿糖胞苷化疗所致的紫外线回忆反应
BMJ Case Rep. 2021 Nov 30;14(11):e246596. doi: 10.1136/bcr-2021-246596.
2
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study.伊达比星、阿糖胞苷和纳武单抗用于新诊断的急性髓系白血病或高危骨髓增生异常综合征患者：一项单臂2期研究。
Lancet Haematol. 2019 Sep;6(9):e480-e488. doi: 10.1016/S2352-3026(19)30114-0. Epub 2019 Aug 7.
3
Enterocolitis as initial presentation of acute myelogenous leukemia exacerbated by induction chemotherapy with idarubicin-cytosine arabinoside.以小肠结肠炎为首发表现的急性髓性白血病，在接受去甲氧柔红霉素-阿糖胞苷诱导化疗后病情加重。
Mayo Clin Proc. 2002 Oct;77(10):1133. doi: 10.4065/77.10.1133.
4
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. Venetoclax 联合克拉屈滨、伊达比星和阿糖胞苷强化化疗治疗初诊急性髓系白血病或高危骨髓增生异常综合征患者：来自单中心、单臂、2 期临床试验的一个队列研究。
Lancet Haematol. 2021 Aug;8(8):e552-e561. doi: 10.1016/S2352-3026(21)00192-7.
5
High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.高剂量阿糖胞苷（24 g/m2）联合伊达比星（HiDAC-3）治疗成人急性髓系白血病，第一周期反应率高，胃肠道毒性有限。
Intern Med J. 2013 Mar;43(3):294-7. doi: 10.1111/j.1445-5994.2012.02868.x.
6
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial).一项在新诊断的具有诱导失败高危风险的急性髓系白血病患者中进行的阿糖胞苷和伊达比星联合递增剂量克拉屈滨的 I/II 期研究（AMLSG 17-10 CIARA 试验）。
Br J Haematol. 2018 Oct;183(2):235-241. doi: 10.1111/bjh.15546.
7
FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.氟达拉滨、阿糖胞苷、伊达比星和依托泊苷（FLAIE），一种用于成人急性髓性白血病的四联诱导化疗方案：单中心经验
Am J Hematol. 2009 Oct;84(10):690-2. doi: 10.1002/ajh.21516.
8
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML).在难治性或复发性急性髓细胞白血病（AML）患者中，作为单一药物或与伊达比星和阿糖胞苷联合使用时，反义寡核苷酸（ASO）LY2181308 的安全性和药代动力学。
Invest New Drugs. 2013 Aug;31(4):1023-34. doi: 10.1007/s10637-013-9935-x. Epub 2013 Feb 10.
9
The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia: A meta-analysis of randomized clinical trials.柔红霉素与伊达比星联合阿糖胞苷用于急性髓性白血病诱导治疗的疗效与安全性：一项随机临床试验的荟萃分析
Medicine (Baltimore). 2020 Jun 12;99(24):e20094. doi: 10.1097/MD.0000000000020094.
10
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.用克拉屈滨、伊达比星和阿糖胞苷（CIA）作为≤60 岁新诊断为急性髓系白血病患者的一线治疗。
Am J Hematol. 2013 Nov;88(11):961-6. doi: 10.1002/ajh.23544. Epub 2013 Sep 9.
本文引用的文献
1
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.大剂量甲氨蝶呤或大剂量阿糖胞苷治疗后出现的手足红斑性感觉异常综合征。
Cancer. 2017 Sep 15;123(18):3602-3608. doi: 10.1002/cncr.30762. Epub 2017 May 11.
2
Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy.吉西他滨引起的放射性回忆性皮炎并不意味着需要停止化疗。
Oncol Lett. 2011 Jan;2(1):85-90. doi: 10.3892/ol.2010.195. Epub 2010 Oct 5.
3
Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.多西他赛/环磷酰胺诱导的紫外线回忆性皮炎。
J Clin Oncol. 2011 Dec 1;29(34):e840-1. doi: 10.1200/JCO.2011.37.3779. Epub 2011 Oct 24.
4
Ultraviolet recall phenomenon associated with methotrexate and cytarabine.与甲氨蝶呤和阿糖胞苷相关的紫外线回忆现象。
J Eur Acad Dermatol Venereol. 2006 Mar;20(3):353-4. doi: 10.1111/j.1468-3083.2006.01432.x.
5
Radiation recall supraglottitis. A hazard in head and neck chemotherapy.放射性回忆性会厌炎。头颈部化疗中的一种风险。
Arch Otolaryngol. 1984 Sep;110(9):614-7. doi: 10.1001/archotol.1984.00800350056015.
Zotero 插件